Release of more study results

Panion Animal Health AB develops a new gene therapy treatment for epilepsy in dogs. The clinical phase of a safety study in dogs under the lead of associate professor David Woldbye at the University of Copenhagen was recently finalized, as reported on August 30, 2018....

Change in number of shares in Panion Animal Health AB (publ)

The issuance of units with pre-emption rights has been fully registered with the Swedish Companies Registration Office. Due to the registration the share capital has increased by SEK 5,486.208556 and the number of shares and the number of votes has increased by...